PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32679123-5	2020	The treatment of nifedipine dose-dependently suppressed H2O2-induced senescence by reducing Ca2+ entry, autophagy impairment and mTOR signaling, and this suppression was found to be related to senescence-associated beta-galactosidase (SA-beta-gal) activity and the expressions of senescence marker protein 30 (SMP30), p53, and p21.	Nifedipine	17-27	tumor protein p53	Homo sapiens	318-321	
10397512-0	1999	Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.	Nifedipine	79-89	tumor protein p53	Homo sapiens	14-17	
10397512-3	1999	METHODS: We immunohistochemically examined the expression of tumor-related markers such as p53 protein and Ki-67 antigen in 11 hyperplastic gingival tissues induced by nifedipine and phenytoin, as well as 5 control tissues using an avidin-biotin-peroxidase complex method.	Nifedipine	168-178	tumor protein p53	Homo sapiens	91-94	
10397512-4	1999	RESULTS: Two specimens out of 4 nifedipine-induced and 4 out of 7 phenytoin-induced hyperplastic gingival tissues revealed the expression of p53 protein in the nuclei of epithelial cells, while no expression of p53 protein was observed in the epithelia of the 5 non-hyperplastic control tissues.	Nifedipine	32-42	tumor protein p53	Homo sapiens	141-144	
12082016-11	2002	A reported clinical association of Tp53 immunopositive colorectal cancers with use of the antihypertensive agents was extended by the demonstration of hydralazine and nifedipine as Tp53-inducers.	Nifedipine	167-177	tumor protein p53	Homo sapiens	35-39	
12082016-11	2002	A reported clinical association of Tp53 immunopositive colorectal cancers with use of the antihypertensive agents was extended by the demonstration of hydralazine and nifedipine as Tp53-inducers.	Nifedipine	167-177	tumor protein p53	Homo sapiens	181-185